Phathom Pharmaceuticals (PHAT) Research & Development (2022 - 2025)
Historic Research & Development for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $7.0 million.
- Phathom Pharmaceuticals' Research & Development fell 1916.48% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.9 million, marking a year-over-year decrease of 1291.49%. This contributed to the annual value of $34.1 million for FY2024, which is 3169.8% down from last year.
- As of Q3 2025, Phathom Pharmaceuticals' Research & Development stood at $7.0 million, which was down 1916.48% from $9.1 million recorded in Q2 2025.
- Phathom Pharmaceuticals' Research & Development's 5-year high stood at $19.0 million during Q3 2022, with a 5-year trough of $7.0 million in Q3 2025.
- In the last 4 years, Phathom Pharmaceuticals' Research & Development had a median value of $11.5 million in 2023 and averaged $12.0 million.
- Its Research & Development has fluctuated over the past 5 years, first plummeted by 4221.25% in 2024, then surged by 2304.77% in 2025.
- Quarter analysis of 4 years shows Phathom Pharmaceuticals' Research & Development stood at $15.9 million in 2022, then dropped by 16.0% to $13.4 million in 2023, then plummeted by 35.92% to $8.6 million in 2024, then fell by 18.13% to $7.0 million in 2025.
- Its Research & Development stands at $7.0 million for Q3 2025, versus $9.1 million for Q2 2025 and $9.2 million for Q1 2025.